1. Home
  2. WTFC vs HALO Comparison

WTFC vs HALO Comparison

Compare WTFC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTFC
  • HALO
  • Stock Information
  • Founded
  • WTFC 1991
  • HALO 1998
  • Country
  • WTFC United States
  • HALO United States
  • Employees
  • WTFC N/A
  • HALO N/A
  • Industry
  • WTFC Major Banks
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WTFC Finance
  • HALO Health Care
  • Exchange
  • WTFC Nasdaq
  • HALO Nasdaq
  • Market Cap
  • WTFC 7.8B
  • HALO 7.4B
  • IPO Year
  • WTFC N/A
  • HALO N/A
  • Fundamental
  • Price
  • WTFC $122.16
  • HALO $50.23
  • Analyst Decision
  • WTFC Strong Buy
  • HALO Buy
  • Analyst Count
  • WTFC 15
  • HALO 9
  • Target Price
  • WTFC $131.67
  • HALO $63.78
  • AVG Volume (30 Days)
  • WTFC 428.9K
  • HALO 2.6M
  • Earning Date
  • WTFC 04-21-2025
  • HALO 05-06-2025
  • Dividend Yield
  • WTFC 1.64%
  • HALO N/A
  • EPS Growth
  • WTFC 4.71
  • HALO 55.40
  • EPS
  • WTFC 10.13
  • HALO 3.76
  • Revenue
  • WTFC $2,383,650,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • WTFC $15.72
  • HALO $24.79
  • Revenue Next Year
  • WTFC $5.34
  • HALO $22.65
  • P/E Ratio
  • WTFC $12.06
  • HALO $13.36
  • Revenue Growth
  • WTFC 8.51
  • HALO 25.64
  • 52 Week Low
  • WTFC $89.10
  • HALO $41.28
  • 52 Week High
  • WTFC $142.04
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • WTFC 67.78
  • HALO 34.42
  • Support Level
  • WTFC $113.39
  • HALO $58.38
  • Resistance Level
  • WTFC $123.46
  • HALO $69.94
  • Average True Range (ATR)
  • WTFC 2.63
  • HALO 3.30
  • MACD
  • WTFC 1.40
  • HALO -0.27
  • Stochastic Oscillator
  • WTFC 92.17
  • HALO 9.30

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: